Daily vs Intermittent Restriction of Energy: Controlled Trial to Reduce Diabetes Risk (DIRECT)
NCT03689608 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 209
Last updated 2022-01-11
Summary
In this randomized controlled trial, the investigators will compare the long term effectiveness of intermittent fasting (IF) versus an energy matched moderate calorie restriction (CR) over 18 months, and relative to a non-active intervention standard control (SC) in individuals who are at increased risk of developing type 2 diabetes. All participants will be required to attend the blood tests following a 12-hour overnight fast for the "A" visit at Month 0, 2, 6 (active) and 18 (follow up).
Fast424hGlucose: A subset of 100 participants enrolled in either IF or CR group in the parent study will be fitted with a continuous glucose monitor (CGM) to measure 24-hour glycaemic profile at month 0 and month 6.
Fast4Switch: Additional bloods will be collected after a "B" visit at month 6 to compare the fed to fasted switch. The B samples will be collected after a 12-hour overnight fast (CR, SC) or 20-hour fast (IF) to assess the metabolic switch to fasting in metabolites and hormones.
Fast4Stress: Additional subcutaneous adipose tissue, urine and saliva samples will be collected in \~32 men in IF and CR groups at month 0 and 6 at A and B visits to examine changes in stress response and resistance markers.
Experience2Fast: In-depth, semi-structured interviews will be carried out at month-8 follow-up visit in a subset of completers from IF or CR groups to explore the experience of intervention diets and understand contributing factors towards change and maintenance of dietary behaviours.
Fast4Flux: Additional blood samples will be collected in \~100 individuals in SC, IF and CR groups at month 0, month 2 and month 6 at A visit to measure autophagic flux in peripheral blood mononuclear cells following treatment of whole blood.
Conditions
- Individuals at Risk of Developing Diabetes
Interventions
- OTHER
-
Intermittent Fasting (IF)
Participants will fast 3 days per week. In fasting days, meal replacements at 30% of daily energy requirements will be provided for the first 6 months. Participants will have fortnightly nutrition assessment.
- OTHER
-
Daily Restriction (DR)
Participants are instructed to restrict energy intake by 30% of daily energy requirements. Meal replacements will be provided for the first 6 months. Participants will have fortnightly nutrition assessment.
- OTHER
-
standard care (SC)
Participants will receive current practice guidelines in a static information format, will not take part in any counselling or receive meal replacements.
Sponsors & Collaborators
-
University of Adelaide
lead OTHER
Principal Investigators
-
Leonie Heilbronn, PhD · The University of Adelaide
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 35 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-26
- Primary Completion
- 2020-11-30
- Completion
- 2021-11-30
Countries
- Australia
Study Locations
More Related Trials
-
Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes
NCT03811587 ·Status: COMPLETED ·Phase: NA
-
Depletion of Liver Fat in Type 2 Diabetes
NCT06211556 ·Status: RECRUITING ·Phase: NA
-
Short Term Intermittent Fasting and Insulin Resistance
NCT02420054 ·Status: UNKNOWN ·Phase: NA
-
Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
NCT05309057 ·Status: UNKNOWN
-
Time-Restricted Feeding on Glucose Homeostasis and Quality of Life
NCT04062773 ·Status: UNKNOWN ·Phase: NA
-
Metabolism of Low Carbohydrate and Ketogenic Diet
NCT05071287 ·Status: COMPLETED ·Phase: NA
-
Restricted Eating Time in the Treatment of Type 2 Diabetes
NCT06152588 ·Status: RECRUITING ·Phase: NA
-
The Fasting II Study
NCT01792986 ·Status: COMPLETED ·Phase: NA
-
Impacts of Intermittent Fasting on Energy Balance and Associated Health Outcomes
NCT02498002 ·Status: COMPLETED ·Phase: NA
-
A Retrospective and Prospective Cohort Study of the 21-day Fasting-like Diet in Patients With Metabolic and Autoimmune Diseases
NCT03193177 ·Status: COMPLETED
-
Intermittent Fasting to Improve Insulin Secretion
NCT04607096 ·Status: RECRUITING ·Phase: NA
-
Metabolic and Hormonal Effects of 5:2 Intermittent Fasting
NCT02450097 ·Status: COMPLETED ·Phase: NA
-
Fasting-Associated Immune-metabolic Remission of Diabetes
NCT05295160 ·Status: COMPLETED ·Phase: NA
-
Intermittent Eating on Glucose Homeostasis in Prediabetes
NCT05717387 ·Status: RECRUITING ·Phase: NA
-
Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes
NCT04283318 ·Status: COMPLETED ·Phase: NA
-
Intermittent Carbohydrate Restriction in Cardiometabolic Health
NCT06684834 ·Status: RECRUITING ·Phase: NA
-
Prolonged Daily Fasting as a Viable Alternative to Caloric Restriction in At-Risk Obese Humans
NCT04259632 ·Status: COMPLETED ·Phase: NA
-
Metabolic Response to 3-day Fast Versus Carbohydrate-free Diet in Type 2 Diabetes
NCT01469104 ·Status: COMPLETED ·Phase: NA
-
The Acute Effects of Eucaloric and Hypocaloric Carbohydrate Restriction on Liver Fat Content and Metabolism in Obese Individuals
NCT05643521 ·Status: UNKNOWN ·Phase: NA
-
Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?
NCT01964118 ·Status: COMPLETED ·Phase: NA
-
The Acute Effect of Low-carb Diet on the Plasma Fatty Acid Composition in Type 2 Diabetes
NCT05498688 ·Status: UNKNOWN ·Phase: NA
-
Effects of Low Fat Versus Low Carbohydrate Diets on Energy Metabolism
NCT03878108 ·Status: COMPLETED ·Phase: NA
-
Biweekly Interval Intermittent Fasting for Type 2 Diabetes, a Safety Study
NCT03938441 ·Status: TERMINATED ·Phase: NA
-
Dietary Interventions in Prediabetes
NCT01729078 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Modification for Obesity-Related Type 2 Diabetes
NCT00415688 ·Status: COMPLETED ·Phase: PHASE4